UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$234M |
| 2 |
Home Depot
HD
|
+$214M |
| 3 |
Intercontinental Exchange
ICE
|
+$206M |
| 4 |
TJX Companies
TJX
|
+$129M |
| 5 |
BorgWarner
BWA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$227M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$212M |
| 3 |
Mohawk Industries
MHK
|
+$137M |
| 4 |
Liberty Global Class A
LBTYA
|
+$114M |
| 5 |
Freeport-McMoran
FCX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.05% |
| 2 | Technology | 13.96% |
| 3 | Financials | 13.95% |
| 4 | Industrials | 9.13% |
| 5 | Energy | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Viasat
VSAT
$11.2B
| $1.18M | ﹤0.01% |
20,299
+600
| +3% | +$36.2K |
|
|
WGL
1477
DELISTED
Wgl Holdings
WGL
| $1.18M | ﹤0.01% |
27,261
+3,200
| +13% | +$129K |
|
1478
Vanguard Total Bond Market
BND
$158B
| $1.17M | ﹤0.01% |
14,222
-382
| -3% | -$31.2K |
|
|
JNS
1479
DELISTED
Janus Capital Group Inc
JNS
| $1.17M | ﹤0.01% |
93,364
| – | – |
|
1480
Designer Brands
DBI
$339M
| $1.16M | ﹤0.01% |
41,518
+900
| +2% | +$28.4K |
|
|
SF
1481
Stifel
SF
$12.8B
| $1.16M | ﹤0.01% |
55,136
| – | – |
|
|
AHT
1482
Ashford Hospitality Trust
AHT
$21M
| $1.16M | ﹤0.01% |
108
+4
| +4% | +$39.7K |
|
1483
Kemper
KMPR
$1.72B
| $1.15M | ﹤0.01% |
31,298
-2,860
| -8% | -$106K |
|
|
HITT
1484
DELISTED
HITTITE MICROWAVE CORP
HITT
| $1.15M | ﹤0.01% |
14,745
+1,146
| +8% | +$73.8K |
|
1485
Royal Bank of Canada
RY
$294B
| $1.15M | ﹤0.01% |
16,043
+497
| +3% | +$33.7K |
|
|
SYA
1486
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $1.15M | ﹤0.01% |
50,397
+1,700
| +3% | +$35.6K |
|
1487
iShares TIPS Bond ETF
TIP
$14.5B
| – | – |
0
| – | – |
|
|
KS
1488
DELISTED
KapStone Paper and Pack Corp.
KS
| $1.14M | ﹤0.01% |
34,298
-500
| -1% | -$14.2K |
|
1489
Embotelladora Andina Series B
AKO.B
$4.93B
| $1.13M | ﹤0.01% |
50,100
| – | – |
|
|
ANFI
1490
DELISTED
AMIRA NATURE FOODS LTD
ANFI
| $1.13M | ﹤0.01% |
82,767
+2,797
| +3% | +$42K |
|
|
TQNT
1491
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
| $1.13M | ﹤0.01% |
71,494
+700
| +1% | +$10.4K |
|
1492
Pilgrim's Pride
PPC
$6.33B
| $1.13M | ﹤0.01% |
41,225
+14,200
| +53% | +$337K |
|
1493
Enviri
NVRI
$647M
| $1.12M | ﹤0.01% |
42,097
-6,429
| -13% | -$164K |
|
1494
Qualys
QLYS
$6.34B
| $1.12M | ﹤0.01% |
43,669
-664
| -1% | -$15.1K |
|
1495
New Jersey Resources
NJR
$5.62B
| $1.11M | ﹤0.01% |
38,980
+1,382
| +4% | +$35.9K |
|
|
SLCA
1496
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $1.11M | ﹤0.01% |
19,999
-2,100
| -10% | -$98.9K |
|
1497
Invesco DB Commodity Index Tracking Fund
DBC
$1.64B
| $1.1M | ﹤0.01% |
41,333
-15,894
| -28% | -$419K |
|
1498
Interactive Brokers
IBKR
$40B
| $1.1M | ﹤0.01% |
188,624
| – | – |
|
|
CRR
1499
DELISTED
Carbo Ceramics Inc.
CRR
| $1.09M | ﹤0.01% |
7,099
| – | – |
|
|
BID
1500
DELISTED
Sotheby's
BID
| $1.09M | ﹤0.01% |
25,898
| – | – |
|
Similar funds
UBS AM's Q2 2014 Portfolio in Review
As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
- UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
- UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
- UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
- UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
- UBS AM opened 81 new positions and closed 97 in Q2 2014.
- UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.
Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.